Clinical trial
Treatment of Cerebral Toxoplasmosis in HIV/AIDS
NCT00367081 · Department of Medical Services Ministry of Public Health of Thailand, Other · Completed
Key facts
| NCT number | NCT00367081 |
|---|---|
| Title | Treatment of Cerebral Toxoplasmosis in HIV/AIDS |
| Official title | Pyrimethamine Plus Sulfadiazine Versus Trimethoprim Plus Sulfamethoxazole for Treatment of Toxoplasmic Encephalitis in AIDS Patients: A Randomized Controlled Trial. |
| Lead sponsor | Department of Medical Services Ministry of Public Health of Thailand, Other |
| Collaborators | Chiang Mai University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Toxoplasmic Encephalitis, AIDS |
| Intervention type | Drug |
| Interventions | TMX-SMX (Bactrim(R)), Pyrimethamine plus Sulfadiazine plus leucoverin |
| Enrollment | 30 |
| Start date | May 1, 2003 |
| Completion | Aug 1, 2004 |
| First posted | Aug 22, 2006 |
| Last update posted | Jul 31, 2007 |
| Countries | Thailand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: